✦ LIBER ✦

A Phase II and Pharmacokinetic Study of Weekly 72-h Topotecan Infusion in Patients with Platinum-Resistant and Paclitaxel-Resistant Ovarian Carcinoma

✍ Scribed by Peter G. Rose; Nahida H. Gordon; Nancy Fusco; Lisa Fluellen; Michael Rodriguez; Stephen T. Ingalls; Charles L. Hoppel

Book ID: 112248153
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 73 KB
Volume: 78
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.2000.5844

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of gemcitabine and weekly

Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer

✍ Agustin A Garcia; Anne O'Meara; Ashim Bahador; Grace Facio; Susan Jeffers; Dae-Y 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB

A Phase I Study of Weekly Topotecan and

A Phase I Study of Weekly Topotecan and Paclitaxel in Previously Treated Epithelial Ovarian Carcinoma Patients

✍ H. Homesley; B. Benigno; J. Williams; L. Vaccarello 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase II trial of lapatinib and topoteca

Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma

✍ S. John Weroha; Ann L. Oberg; Katie L. Allen Ziegler; Shaker R. Dakhilm; Kendrit 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Role of salvage chemotherapy with topote

Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

✍ Ghamande, Sharad A.; Piver, M. Steven 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

## Background and Objectives: We assessed the role of salvage chemotherapy with topotecan and cisplatin in patients with platinum-and paclitaxel-resistant advanced and recurrent ovarian or primary peritoneal cancer, based on the reported in vivo and in vitro synergism between these two drugs. Meth

A phase II trial of weekly topotecan for

A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy

✍ Whitney A. Spannuth; Charles A. Leath III; Warner K. Huh; Mack N. Barnes III; Su 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Phase II trial of weekly paclitaxel (80

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

✍ Maurie Markman; John Blessing; Stephen C. Rubin; Joseph Connor; Parviz Hanjani; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 97 KB